Clinical trial results push St. Louis cancer screening startup toward commercialization


St. Louis life sciences startup Geneoscopy is taking steps toward commercializing its at-home, preventive screening test for colorectal cancer after a clinical trial yielded strong results.

Previous 'A big deal:' Startup NeuroDyne improves EEG innovation, gears up for $3.4M funding target
Next Inova Health System is making changes to meet long-term demand for care